it’s oncology, not what they do. Vifor at least has some strategic overlap because kidney disease patients periodically go to clinics for treatment, like PID/CIDP patients that get immunoglobulin
it’s oncology, not what they do. Vifor at least has some...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$311.12 |
Change
3.100(1.01%) |
Mkt cap ! $150.3B | |||
| Open | High | Low | Value | Volume |
| $308.75 | $311.12 | $306.32 | $220.9M | 712.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1100 | $310.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $311.13 | 1131 | 2 |
View Market Depth
| Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
| CSL (ASX) Chart |